読み込み中
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
前日終値
$3.84
+$0.03 · +0.79%
日中の時刻はETです。市場データは遅延する場合があります。
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
日中レンジ
現在 $3.84
52週レンジ
現在 $3.84
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
46
適正価値
センチメント
56
まちまち
リスク
75
高リスク
モメンタム
18
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
日中レンジ
現在 $3.84
52週レンジ
現在 $3.84
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Extended Market ETFVXF
Vanguard Morningstar Total Stock Market ETFVTI
iShares Micro-Cap ETFIWC
U.S. Micro Cap Portfolio ETFDFMCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
